Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.
A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.
Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.
More top news
Chilly start, some frost, any mistiness clearing and brighter breaks developing
Emma Jesson brings you Sunday night's forecast
Not too much rain in the forecast outlook, apart from on Wednesday